Background. Although data about the incidence and management of biliary complications after deceased-donor liver transplantation (DDLT) are well defined, those pertaining to adult living-donor liver transplantation (LDLT) are conflicting. Methods. We retrospectively compared endoscopic retrograde cholangio-pancreatography (ERCP) findings in 30 LDLT vs. 357 DDLT consecutive adult recipients with duct-to-duct biliary reconstruction. LDLT and DDLT recipients were followed up for median durations of 30.5 and 36.0 months after the last ERCP, respectively. Results. Postoperative biliary complications were more frequently identified at ERCP after LDLT versus DDLT (10/ DDLT recipients, respectively; Pϭ0.005; some patients had both complications). Stricture dilation was successful in 4/10 (40%) LDLT vs. 27/27 (100%) DDLT recipients (PϽ0.001), and bile ducts remained patent up to the end of follow-up without further intervention in 2/10 (20.0%) vs. 21/27 (77.8%) patients, respectively (Pϭ0.002). Endoscopic treatment of bile leaks was successful in 3/4 (75.0%) vs. 5/6 (83.3%) LDLT versus DDLT recipients, respectively (NS). Conclusions. Biliary complications were more frequent after LDLT compared with DDLT. Endoscopic treatment of anastomotic biliary strictures was successful in a minority of patients after LDLT, in contrast with DDLT. Most biliary leaks were successfully treated at endoscopy after LDLT or DDLT.
S
ince the first description of living-donor liver transplantation (LDLT) in a pediatric patient (1) , this operation has gained popularity in adult patients due to the shortage of cadaveric livers (2) . Because LDLT was first performed in patients with biliary atresia, restoration of biliary continuity after LDLT has initially been performed using hepaticojejunostomy. More recently, the use of duct-to-duct biliary anastamoses in LDLT has been popularized due to the supposed advantages of this technique (e.g., easier endoscopic access and absence of biliary contamination by digestive content; 3). However, performing duct-to-duct biliary anastamoses in LDLT is one of the most challenging technical aspects of this procedure, due to the small diameter of the intrahepatic bile ducts and the high incidence of aberrant biliary anatomy (4) .
With an incidence of approximately 30%, biliary complications are the greatest cause of morbidity after LDLT (5) . The spectrum of complications includes biliary stones, bile leaks originating from various sites, and biliary strictures. Limited published data have suggested that the incidence of biliary complications is higher after LDLT compared with deceased-donor liver transplantation (DDLT), but data are conflicting (6 -9) . Also, although endoscopic treatment is accepted as a first-line therapy to treat biliary complications after DDLT (10) , limited data are available with regard to LDLT (7) (8) (9) (11) (12) (13) .
We, retrospectively, reviewed biliary complications that developed after LDLT versus DDLT in a liver transplantation cohort from a single institution, and compared short-and longterm success of endoscopic treatment in both populations. January 1995 and December 2006 for endoscopic treatment of suspected biliary complications after liver transplantation were included. Referral was at the discretion of the liver transplant team, which comprised hepatologists and liver transplant surgeons; only patients with duct-to-duct biliary reconstruction were referred for endoscopic retrograde cholangio-pancreatography (ERCP), those with biliodigestive anastamoses being referred for percutaneous cholangiography. Between January 1988 and December 2006, 433 liver transplantations were performed in this hospital in 408 adult patients, including 34 LDLT (30 with duct-to-duct anastomosis and four with biliodigestive anastomosis), starting in November 1998 and 399 DDLT (357 with choledocho-choledochostomy and 42 with a biliodigestive anastomosis). The study population, therefore, comprised 357 DDLT recipients and 30 LDLT recipients, of whom 58 (16.2%) and five (16.7%) patients, respectively, received liver transplantation after the introduction of the model for end-stage liver disease (MELD) score as a policy to allocate liver grafts in Argentina (July 2005). All LDLTs were performed by hepatobiliary surgeons with extensive experience in DDLT and pediatric LDLT; right hepatectomy grafts from adult donors were used in all but one case (a left hepatectomy graft was used in the remaining patient), and biliary reconstructions consisted of duct-to-duct anastomoses (with T-tube insertion in a single patient). Data collected prospectively included age, gender, indication for transplantation, type of graft and of biliary reconstruction, details of the endoscopic procedures, potential complications, and their management. Patients gave informed consent for all the procedures; the study complied with the Declaration of Helsinki regarding investigation in humans, and it was approved by the institutional ethics committee.
Methods of Treatment
If a biliary complication was suspected based on clinical and laboratory data, this was assessed by magnetic resonance cholangiography after exclusion of liver graft rejection and of hepatic artery thrombosis at histopathology and Doppler ultrasonography, respectively. All ERCPs were performed under general anesthesia by experienced therapeutic biliary endoscopists after routine administration of antibiotic prophylaxis. Endoscopic biliary sphincterotomy was performed in all cases and a variety of guidewires (Wilson-Cook Medical, Inc., Winston-Salem, NC; Terumo, Tokyo, Japan; Boston Scientific Co., Boston, MA), measuring 0.018, 0.025, or 0.035 inch in diameter, were used (usually with a Torque device) for deep biliary cannulation and to secure access to the intrahepatic bile ducts. Bile duct stones or casts detected by cholangiography were extracted during the same session using Dormia baskets or Fogarty-type catheters. Strictures were dilated using 8 or 10 mm in diameter balloon catheters (Hurricane; Boston Scientific Co.), and this was followed by attempted insertion of transpapillary plastic biliary stents (Wilson-Cook Medical) starting in 2000. In case of stent insertion, stent removal was scheduled 3 months later and, at the time of repeat ERCP, no stent was inserted and no further endoscopic treatment was recommended if bile leak was resolved or if stricture dilation was judged satisfactory using previously published criteria (14, 15) . Otherwise, stenting was repeated and ERCP was planned 3 months later.
Definitions
Follow-up duration was calculated from the time of last ERCP up to death or to the end of follow-up. Bile leak resolution was defined as the absence of contrast medium leakage during repeat cholangiography at the time of stent retrieval or, if ERCP was not repeated, as clinical and radiological resolution without subsequent biliary procedure required during follow-up. Biliary stricture resolution was defined as the absence of cholestasis (alkaline phosphatases Ͻ2ϫupper limit of normal values) and of intrahepatic bile duct dilation at ultrasonography during follow-up (14, 15) . Short-term success was defined (1) for biliary strictures, as successful endoscopic biliary stricture dilation (possibly associated with stent insertion) followed by Ն50% decrease in serum bilirubin level within 10 days following ERCP and (2) for biliary leaks, as bile leak resolution within 10 days after ERCP. Longterm success was defined according to previous criteria (15) , as the absence of both of the following during follow-up: (1) any episode of cholangitis (2) increase in serum alkaline phosphatase associated with biliary stricture dilation judged unsatisfactory at magnetic resonance cholangiography or repeat ERCP.
Statistical Analyses
Categorical variables were summarized by counts and proportions; continuous variables were summarized by their median value with the ranges under parentheses. Two-tailed Fisher's exact test was used to test differences between categorical variables, and the Wilcoxon rank sum test was used to compare continuous variables. P values less than 0.05 were considered as statistically significant. Analyses were performed with JMP software (version 5.1.2, SAS, Cary, NC). (19 -42) vs. 23 (14 -41), respectively; Pϭ0.388). Among 10 LDLT recipients referred for ERCP, seven had a single duct-to-duct biliary anastomosis and three had two duct-to-duct anastomoses (between the recipient's right and left hepatic ducts and the donor's right anterior and posterior sectorial hepatic ducts). All LDLT recipients referred for ERCP had anastomotic strictures (plus bile leaks and stones in 4 and 2 cases, respectively); in the 34 DDLT recipients, main findings at ERCP included anastomotic strictures (nϭ24), bile leaks (nϭ3), bile leaks plus anastomotic strictures (nϭ3), and biliary stones (nϭ4). Anastomotic strictures in DDLT recipients were associated with biliary stones, casts, or sludge in 11 (41%) cases.
RESULTS

Patient
Biliary Strictures
Biliary strictures were more frequently diagnosed at ERCP after LDLT compared with DDLT (10/30 [33.3%] vs. 27/357 [7.6%]; PϽ0.001). All strictures were located at the anastomotic level (Table 2) . Stricture dilation was successful in 4/10 (40%) LDLT vs. 27/27 (100%) DDLT recipients (PϽ0.001). In the six LDLT recipients with failed stricture dilation, a guidewire could not be passed through the stricture despite the use of various tricks; the four remaining patients had stricture dilation using a balloon, associated with plastic biliary stenting in two cases (Table 3) . Stricture resolution was observed in the two patients who had received balloon dilation plus stenting, and long-term success ensued (liver function tests are normal 41 months after stent removal in one patient and the other one developed liver insufficiency related to relapsing hepatitis C virus infection that eventually leaded to death 17 months after stent removal). The two patients who had only stricture dilation experienced persisting cholestasis, and they were referred for percutaneous biliary drainage (long-term success rate of endoscopic treatment in LDLT recipients, 20%). Globally, 8 (80%) LDLT recipients had failed endoscopic treatment; they were referred for percutaneous stricture dilation (nϭ6), hepatico-jejunostomy (nϭ1), or DDLT (nϭ1). Percutaneous treatment was successful in three of six attempted cases; two of the three patients with failed percutaneous treatment are doing well after hepatico-jejunostomy and DDLT, whereas the remaining patient (the single one who had received a left hepatectomy graft and also had a bile leak) died due to sepsis after failed percutaneous biliary drainage scheduled on an elective basis 2 months after ERCP.
In contrast, endoscopic stricture dilation was successful in all of 27 DDLT recipients who had an anastomotic stricture, and this was complemented with plastic biliary stenting in 18 (66.7%) cases. During a median follow-up of 35 (IQR, 10 -91) months after the last ERCP, 6 (22.2%) of these 27 patients had a relapsing stricture, including 2 (22.2%) of 9 patients treated with dilation alone and 4 (22.2%) of 18 patients treated with stricture dilation plus plastic biliary stenting. Stricture relapse was diagnosed at a median of 5 months after the last ERCP. Relapsing strictures were successfully treated by hepatico-jejunostomy (nϭ5) or repeat endoscopic biliary stenting (nϭ1).
Globally, long-term success of endoscopic dilation of anastomotic strictures complicating LDLT and DDLT was achieved in 2/10 (20.0%) and 21/27 (77.8%) patients, respectively (Pϭ0.002). To take into account potential confounding factors related to changes in the endoscopic technique during the study period, results were compared between LDLT and DDLT recipients who had their first endoscopic treatment after March 2002. In this subgroup analysis also, long-term success of endoscopic treatment was significantly higher in DDLT versus LDLT recipients (11/13 [85%] vs. 2/10 [20%], respectively; Pϭ0.003).
Biliary Leaks
Biliary leaks were more frequently diagnosed at ERCP after LDLT compared with DDLT (4/30 [13.3%] vs. 6/357 [1.7%], respectively; Pϭ0.005). After LDLT, leaks were located at the cut surface of the partial liver graft in most cases (Table 2) . Endoscopic treatment included biliary sphincterotomy (this was performed in all liver transplant recipients referred for ERCP), plus stone extraction (nϭ2) or biliary stenting (nϭ2). Bile leak resolved in 3 (75.0%) LDLT recipients; no bile leak recurrence was detected in these three patients after a follow-up of 29, 40, and 48 months, respectively. The remaining patient was the patient who had received a left a Biliary strictures and leaks were both detected in three DDLT recipients and four LDLT recipients. (21) . b This patient eventually underwent percutaneous treatment because the stricture could not be traversed despite repeated endoscopic attempts, although bile leak had resolved after biliary sphincterotomy.
hepatectomy graft and who died after failed percutaneous biliary drainage. In DDLT recipients, endoscopic biliary sphincterotomy plus stenting was performed in five of six cases, and this was always followed by bile leak resolution. The remaining patient had a complete bile duct disruption, and he was referred for hepatico-jejunostomy.
Treatment Complications
Post-ERCP complications developed in 1 (10.0%) LDLT recipient (cholangitis successfully treated by temporary percutaneous transhepatic biliary drainage) and 3 (8.8%) DDLT recipients (one mild pancreatitis and two cholangitis that resolved with medical treatment). 7, 16) . However, a larger series (nϭ429) has reported identically low incidences of biliary complications (5.8%) after LDLT or DDLT (6) . In one of the series cited above (7), bile leaks were extremely frequent (53%) suggesting that a technical factor might have contributed to a significant proportion of these complications. Indeed, some technical factors (namely, an interrupted rather than a continuous suture and performance of multiple biliary anastomoses) are known to favor the development of biliary complications after LDLT (17, 18) . Surgical expertise has also likely contributed to the exceptionally low incidence of biliary complications after LDLT reported by Park et al. (5.8%; 6) , although the role of other factors in this series (e.g., biliary complications had to be confirmed by endoscopic or percutaneous cholangiography to fulfill definition criteria, type of anastomosis [not stated]) cannot be excluded. This high incidence of biliary complications after LDLT compared with DDLT has lead to a significant reduction in the number of LDLT in many centers.
DISCUSSION
Duct-to-duct biliary reconstruction is favored over hepatico-jejunostomy for LDLT in many centers (as it is for DDLT) to prevent ascending cholangitis and to facilitate endoscopic access to the bile ducts (3). However, in our experience, the endoscopic treatment of biliary complications (in particular that of anastomotic stenosis) was disappointing after LDLT, whereas it yielded results in LDLT recipients that were as good as those reported by other authors (14, 19, 20) . Five other series including at least 10 patients have reported the results of endoscopic treatment for anastomotic biliary strictures ( Figs. 1 and 2) complicating LDLT, and short-term success rates were higher compared with our series (63%-71% vs. 40%) (8, (11) (12) (13) 21) . This difference in success rates may, in our opinion, be attributed to anatomical findings. "Crane-neck deformity" and a pouched shape (Fig. 3) of the distal part of the anastomosis after LDLT have been described as ERCP findings that were associated with significantly lower success rates of endoscopic treatment (20% and 25%, respectively) compared with other anatomical presentations (21, 22) . The proportion of LDLT recipients with a "crane-neck deformity" in our series was exceptionally high (30% vs. 7% in another large series; 22) , and this has likely contributed to our low success rate. Another difficulty reported by other authors in LDLT recipients that we also frequently encountered was an inadequate positioning of the endoscope, not "in front of the papilla" (the duodenoscope was sharply bent in the antrum, due to compression by the liver graft) (13) .
Finally, bile leaks in our LDLT recipients were most frequently located at the level of the cut surface of liver grafts, in contrast with previous studies that reported leaks at the anastomosis level in more than 80% of cases (7, 8) . The low incidence of anastomotic leaks in our patients is possibly related to the absence of external stent tube in our patients: external stent tubes have been shown in a randomized trial to be associated with an increased incidence of biliary complications in DDLT, including biliary leakage after tube removal, but their use in LDLT is controversial (3, 18) . As for cutsurface leaks, their incidence is in keeping with reports from other series, and it can be reduced by experience, with meticulous attention in the section plane, and testing with injection of preservation solution during preparation of the graft on the backtable. With regard to the endoscopic treatment of bile leaks after LDLT, our success rate was similar to those reported in other series (the single patient with unsuccessful endoscopic treatment had a leak-located upstream from a tight stricture ; 7, 8, 11, 12) .
In summary, biliary complications were significantly more frequent after LDLT compared with DDLT, and they were less amenable to endoscopic treatment. Endoscopic treatment was successful in a minority of LDLT recipients only, in contrast with the good results in DDLT recipients. The low success rate of endoscopic treatment in LDLT recipients was likely attributable to biliary anatomy, that is challenging to the endoscopist.
